{
 "companyname": "CEL SCI CORP",
 "symbol": "CVM",
 "description": "Biological Products, Except Diagnostic Substances",
 "quarters": [
  {
   "cik": "0000725363",
   "companyname": "CEL SCI CORP",
   "entityid": 839,
   "primaryexchange": "NYSE MKT",
   "primarysymbol": "CVM",
   "siccode": "2836",
   "sicdescription": "Biological Products, Except Diagnostic Substances",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "12/11/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "9/30/2015",
   "original": true,
   "formtype": "10-K",
   "fiscalyear": 2015,
   "fiscalquarter": 4,
   "dcn": "0001354488-15-005519",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "true",
   "amended": false,
   "changeincurrentassets": 498540,
   "changeincurrentliabilities": 1747420,
   "changeininventories": 13668,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -16783,
   "cashfromfinancingactivities": -132689,
   "cashfrominvestingactivities": -27493,
   "cashfromoperatingactivities": -5343563,
   "cfdepreciationamortization": 22500,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": null,
   "netchangeincash": -5503745,
   "totaladjustments": 4500392,
   "ebit": -8339986,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": 0,
   "grossprofit": -66304,
   "incomebeforetaxes": -9843955,
   "interestexpense": -5103,
   "netincome": -9843955,
   "netincomeapplicabletocommon": -9843955,
   "researchdevelopmentexpense": 5366275,
   "totalrevenue": -66304,
   "sellinggeneraladministrativeexpenses": 2864088,
   "commonstock": 1123606,
   "deferredcharges": 4044473,
   "cashandcashequivalents": 5726682,
   "cashcashequivalentsandshortterminvestments": 5726682,
   "goodwill": null,
   "intangibleassets": 291564,
   "inventoriesnet": 1401839,
   "minorityinterest": null,
   "otherassets": 1970917,
   "othercurrentassets": 637793,
   "othercurrentliabilities": 0,
   "otherequity": null,
   "otherliabilities": 13691587,
   "preferredstock": 0,
   "propertyplantequipmentnet": 307466,
   "retainedearnings": -274201479,
   "totalassets": 15447603,
   "totalcurrentassets": 8833183,
   "totalcurrentliabilities": 6850594,
   "totalliabilities": 20677846,
   "totallongtermdebt": 0,
   "totalreceivablesnet": 87214,
   "totalshorttermdebt": 1258209,
   "totalstockholdersequity": -5230243,
   "treasurystock": null
  },
  {
   "cik": "0000725363",
   "companyname": "CEL SCI CORP",
   "entityid": 839,
   "primaryexchange": "NYSE MKT",
   "primarysymbol": "CVM",
   "siccode": "2836",
   "sicdescription": "Biological Products, Except Diagnostic Substances",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "8/7/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "6/30/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 3,
   "dcn": "0001354488-15-003627",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": -190927,
   "changeincurrentliabilities": 1310278,
   "changeininventories": 151998,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": 0,
   "cashfromfinancingactivities": 14870845,
   "cashfrominvestingactivities": -7564,
   "cashfromoperatingactivities": -6247213,
   "cfdepreciationamortization": 50913,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": null,
   "netchangeincash": 8616068,
   "totaladjustments": -1818076,
   "ebit": -8201475,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": -641276,
   "grossprofit": 389223,
   "incomebeforetaxes": -3787861,
   "interestexpense": -41595,
   "netincome": -4429137,
   "netincomeapplicabletocommon": -4429137,
   "researchdevelopmentexpense": 5692568,
   "totalrevenue": 389223,
   "sellinggeneraladministrativeexpenses": 2847217,
   "commonstock": 1120271,
   "deferredcharges": 4216214,
   "cashandcashequivalents": 11230427,
   "cashcashequivalentsandshortterminvestments": 11230427,
   "goodwill": null,
   "intangibleassets": 300701,
   "inventoriesnet": 1415507,
   "minorityinterest": null,
   "otherassets": 1970917,
   "othercurrentassets": 651897,
   "othercurrentliabilities": 0,
   "otherequity": null,
   "otherliabilities": 12165249,
   "preferredstock": 0,
   "propertyplantequipmentnet": 339835,
   "retainedearnings": -264357524,
   "totalassets": 21495844,
   "totalcurrentassets": 14668177,
   "totalcurrentliabilities": 5272774,
   "totalliabilities": 17569226,
   "totallongtermdebt": 2309,
   "totalreceivablesnet": 158492,
   "totalshorttermdebt": 1278892,
   "totalstockholdersequity": 3926618,
   "treasurystock": null
  },
  {
   "cik": "0000725363",
   "companyname": "CEL SCI CORP",
   "entityid": 839,
   "primaryexchange": "NYSE MKT",
   "primarysymbol": "CVM",
   "siccode": "2836",
   "sicdescription": "Biological Products, Except Diagnostic Substances",
   "usdconversionrate": 1,
   "restated": false,
   "receiveddate": "5/8/2015",
   "preliminary": false,
   "periodlengthcode": "m",
   "periodlength": 3,
   "periodenddate": "3/31/2015",
   "original": true,
   "formtype": "10-Q",
   "fiscalyear": 2015,
   "fiscalquarter": 2,
   "dcn": "0001354488-15-002235",
   "currencycode": "USD",
   "crosscalculated": true,
   "audited": "false",
   "amended": false,
   "changeincurrentassets": -42872,
   "changeincurrentliabilities": -86352,
   "changeininventories": -332477,
   "dividendspaid": null,
   "effectofexchangerateoncash": null,
   "capitalexpenditures": -39516,
   "cashfromfinancingactivities": -2097,
   "cashfrominvestingactivities": -41374,
   "cashfromoperatingactivities": -6803405,
   "cfdepreciationamortization": 55905,
   "changeinaccountsreceivable": null,
   "investmentchangesnet": null,
   "netchangeincash": -6846876,
   "totaladjustments": 5752831,
   "ebit": -7759343,
   "costofrevenue": null,
   "discontinuedoperations": null,
   "equityearnings": null,
   "accountingchange": null,
   "extraordinaryitems": null,
   "grossprofit": 197620,
   "incomebeforetaxes": -12556236,
   "interestexpense": -41628,
   "netincome": -12556236,
   "netincomeapplicabletocommon": -12556236,
   "researchdevelopmentexpense": 5035544,
   "totalrevenue": 197620,
   "sellinggeneraladministrativeexpenses": 2865514,
   "commonstock": 915491,
   "deferredcharges": 4387574,
   "cashandcashequivalents": 2614359,
   "cashcashequivalentsandshortterminvestments": 2614359,
   "goodwill": null,
   "intangibleassets": 307900,
   "inventoriesnet": 1567505,
   "minorityinterest": null,
   "otherassets": 1970917,
   "othercurrentassets": 666001,
   "othercurrentliabilities": 24000,
   "otherequity": null,
   "otherliabilities": 8566809,
   "preferredstock": 0,
   "propertyplantequipmentnet": 364247,
   "retainedearnings": -259928387,
   "totalassets": 12725860,
   "totalcurrentassets": 5695222,
   "totalcurrentliabilities": 3679419,
   "totalliabilities": 12382804,
   "totallongtermdebt": 4583,
   "totalreceivablesnet": 37432,
   "totalshorttermdebt": 1112814,
   "totalstockholdersequity": 343056,
   "treasurystock": null
  }
 ]
}